Dihydroergocristine mesylate is a methanesulfonic acid salt of dihydroergocristine, an ergot alkaloid derivative. It has been employed as an active pharmaceutical ingredient for symptomatic management of mental decline associated with cerebrovascular insufficiency and in peripheral vascular disease.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 24730-10-7
Dihydroergotamine mesylate
pharmaceutical raw material
Dihydro-α-ergocryptine mesylate
pharmaceutical raw material
(S,E)-N-(4-((4-CHLORO-3-FLUOROPHENYL)AMINO)-7-((TETRAHYDROFURAN-3-YL)OXY)QUINAZOLIN-6-YL)-4-(DIMETHYLAMINO)BUT-2-ENAMIDE
pharmaceutical raw material
(-)-epiafzelechin
pharmaceutical raw material
Prasteronyl Abiraterone
pharmaceutical raw material
(3alpha)-3-Acetate-17-(3-pyridinyl)-androsta-5,16-dien-3-ol
pharmaceutical raw material
Acidihydroergocristine
pharmaceutical raw material
(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
SPXACGZWWVIDGR-SPZWACKZSA-N
CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O